APA (7th ed.) Citation

S, D., BS, S., M, R., Y, A., S, P., S, C., . . . I, P. (2026). Trastuzumab-Conjugated Nanoliposomes for Targeted Capecitabine Delivery to Suppress HER2-Positive Breast Tumor: Efficacy Analysis in NOD SCID Mice Xenografts. International journal of nanomedicine, 21, 618476. https://doi.org/10.2147/IJN.S618476

Chicago Style (17th ed.) Citation

S, Das, et al. "Trastuzumab-Conjugated Nanoliposomes for Targeted Capecitabine Delivery to Suppress HER2-Positive Breast Tumor: Efficacy Analysis in NOD SCID Mice Xenografts." International Journal of Nanomedicine 21 (2026): 618476. https://doi.org/10.2147/IJN.S618476.

MLA (9th ed.) Citation

S, Das, et al. "Trastuzumab-Conjugated Nanoliposomes for Targeted Capecitabine Delivery to Suppress HER2-Positive Breast Tumor: Efficacy Analysis in NOD SCID Mice Xenografts." International Journal of Nanomedicine, vol. 21, 2026, p. 618476, https://doi.org/10.2147/IJN.S618476.